Skip to main content
Fig. 2 | Cost Effectiveness and Resource Allocation

Fig. 2

From: Comparing swab- and different symptoms-based strategies to ascertain COVID-19 recovery in healthcare workers: a cost-effectiveness analysis

Fig. 2

Scatterplot for 10,000 Monte Carlo iterations of costs and effectiveness for the four competing strategies (A). Incremental cost-effectiveness ratio plot. SW was dominated by all the different symptoms-based strategies. SY14-17 was the most cost-effectiveness strategy (B). SW: swab-based strategy; SY10-17: symptoms-based strategy with swabs scheduled at 10 and 17 days; SY14-17: symptoms-based strategy with swabs scheduled at 14 and 17 days; SY17: symptoms-based strategy with one swab at 17 days

Back to article page